Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Willis Towers Watson PLC a un objectif de cours consensus de $332.67, basé sur les évaluations des 24 analystes. Le plus élevé est de $400 attribué par Raymond James le septembre 22, 2025, et le plus bas est de $257 attribué par Baird le mai 1, 2023. Les 3 dernières évaluations d'analystes ont été publiées par UBS, Wells Fargo et Piper Sandler le octobre 8, 2025, octobre 8, 2025 et octobre 6, 2025. Avec un objectif de cours moyen de $389 entre UBS, Wells Fargo et Piper Sandler, il y a une variation implicite de 22.44% upside pour Willis Towers Watson PLC à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
Wells Fargo
Piper Sandler
Evercore ISI Group
Keefe, Bruyette & Woods
1calculé à partir des notes des analystes
Notes d'analystes pour Willis Towers Watson
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/08/2025 | 25.27% | UBS | $395 → $398 | Maintains | Buy | |||
10/08/2025 | 20.23% | Wells Fargo | $377 → $382 | Maintains | Overweight | |||
10/06/2025 | 21.81% | Piper Sandler | $369 → $387 | Maintains | Overweight | |||
10/01/2025 | 21.81% | Evercore ISI Group | $373 → $387 | Maintains | Outperform | |||
09/30/2025 | 18.66% | Wells Fargo | $358 → $377 | Maintains | Overweight | |||
09/29/2025 | 17.09% | Keefe, Bruyette & Woods | $366 → $372 | Maintains | Outperform | |||
09/22/2025 | 25.9% | Raymond James | $380 → $400 | Reiterates | Strong Buy → Strong Buy | |||
08/18/2025 | 8.59% | Morgan Stanley | $335 → $345 | Maintains | Equal-Weight | |||
08/13/2025 | 10.48% | Citigroup | → $351 | Initiates | → Neutral | |||
07/10/2025 | 16.14% | Wells Fargo | $387 → $369 | Maintains | Overweight | |||
07/07/2025 | -4% | Barclays | $316 → $305 | Maintains | Underweight | |||
04/28/2025 | 15.2% | Keefe, Bruyette & Woods | $371 → $366 | Maintains | Outperform | |||
04/11/2025 | -0.54% | Barclays | $302 → $316 | Maintains | Underweight | |||
04/11/2025 | 16.77% | Jefferies | $373 → $371 | Maintains | Buy | |||
04/09/2025 | — | Keefe, Bruyette & Woods | — | Maintains | Outperform | |||
03/18/2025 | 24.33% | UBS | $344 → $395 | Upgrade | Neutral → Buy | |||
02/10/2025 | 17.4% | Jefferies | $382 → $373 | Maintains | Buy | |||
01/14/2025 | 8.59% | Wells Fargo | $380 → $345 | Maintains | Overweight | |||
01/10/2025 | 21.81% | Keefe, Bruyette & Woods | $378 → $387 | Maintains | Outperform | |||
12/05/2024 | 25.9% | Raymond James | $365 → $400 | Upgrade | Outperform → Strong Buy | |||
12/04/2024 | 19.6% | Truist Securities | $365 → $380 | Reiterates | Buy → Buy | |||
12/04/2024 | 18.97% | Keefe, Bruyette & Woods | $359 → $378 | Maintains | Outperform | |||
11/21/2024 | -4.95% | Barclays | $278 → $302 | Maintains | Underweight | |||
11/05/2024 | 12.99% | Keefe, Bruyette & Woods | $352 → $359 | Maintains | Outperform | |||
11/04/2024 | 7.01% | Wells Fargo | $334 → $340 | Maintains | Overweight | |||
10/09/2024 | -1.17% | Jefferies | $295 → $314 | Maintains | Hold | |||
10/03/2024 | 5.13% | Wells Fargo | $321 → $334 | Maintains | Overweight | |||
10/02/2024 | 8.59% | Roth MKM | $315 → $345 | Maintains | Buy | |||
10/02/2024 | 14.88% | Truist Securities | $335 → $365 | Maintains | Buy | |||
09/04/2024 | -12.5% | Barclays | → $278 | Initiates | → Underweight | |||
07/31/2024 | 1.66% | Keefe, Bruyette & Woods | $320 → $323 | Maintains | Outperform | |||
07/26/2024 | -0.85% | Roth MKM | $300 → $315 | Maintains | Buy | |||
07/26/2024 | 5.44% | Truist Securities | $310 → $335 | Maintains | Buy | |||
07/26/2024 | 1.03% | Wells Fargo | $318 → $321 | Maintains | Overweight | |||
07/10/2024 | -14.39% | Morgan Stanley | $275 → $272 | Maintains | Equal-Weight | |||
06/20/2024 | 0.09% | Wells Fargo | $317 → $318 | Maintains | Overweight | |||
05/22/2024 | -4.32% | B of A Securities | $272 → $304 | Upgrade | Underperform → Neutral | |||
05/06/2024 | -2.11% | Keefe, Bruyette & Woods | $317 → $311 | Maintains | Outperform | |||
04/29/2024 | -1.8% | Citigroup | $315 → $312 | Maintains | Buy | |||
04/26/2024 | -7.15% | Evercore ISI Group | — | $290 → $295 | Maintains | In-Line | ||
04/26/2024 | -4.63% | Piper Sandler | $297 → $303 | Maintains | Overweight | |||
04/11/2024 | 0.09% | Wells Fargo | $320 → $318 | Maintains | Overweight | |||
04/10/2024 | -0.23% | Keefe, Bruyette & Woods | $307 → $317 | Maintains | Outperform | |||
03/28/2024 | -0.85% | Raymond James | $295 → $315 | Reiterates | Outperform → Outperform | |||
02/13/2024 | -0.85% | Citigroup | $236 → $315 | Upgrade | Neutral → Buy | |||
02/12/2024 | -6.21% | BMO Capital | → $298 | Upgrade | Underperform → Market Perform | |||
02/12/2024 | -0.85% | Citigroup | $236 → $315 | Upgrade | Neutral → Buy | |||
02/07/2024 | -15.65% | Stifel | $236 → $268 | Maintains | Hold | |||
02/07/2024 | -2.43% | Truist Securities | $275 → $310 | Maintains | Buy | |||
02/07/2024 | -15.02% | Morgan Stanley | $248 → $270 | Maintains | Equal-Weight | |||
02/07/2024 | -5.58% | Roth MKM | $275 → $300 | Maintains | Buy | |||
02/07/2024 | 0.72% | Wells Fargo | $288 → $320 | Maintains | Overweight | |||
01/11/2024 | -9.35% | Wells Fargo | $248 → $288 | Upgrade | Equal-Weight → Overweight | |||
01/10/2024 | -0.54% | TD Cowen | → $316 | Initiates | → Outperform | |||
10/31/2023 | -19.74% | Raymond James | $250 → $255 | Maintains | Outperform | |||
10/27/2023 | -15.96% | Piper Sandler | $265 → $267 | Maintains | Overweight | |||
10/27/2023 | -13.44% | Truist Securities | $265 → $275 | Maintains | Buy | |||
10/27/2023 | -25.72% | Morgan Stanley | $225 → $236 | Maintains | Equal-Weight | |||
10/11/2023 | -29.18% | Morgan Stanley | $245 → $225 | Maintains | Equal-Weight | |||
10/06/2023 | -28.87% | Jefferies | $218 → $226 | Maintains | Hold | |||
09/19/2023 | -29.81% | Citigroup | $221 → $223 | Maintains | Neutral | |||
09/13/2023 | -16.59% | Piper Sandler | $270 → $265 | Maintains | Overweight | |||
08/28/2023 | -21.31% | Roth MKM | $285 → $250 | Maintains | Buy | |||
08/09/2023 | -30.44% | Citigroup | $251 → $221 | Maintains | Neutral | |||
08/08/2023 | -35.48% | BMO Capital | $230 → $205 | Downgrade | Market Perform → Underperform | |||
07/31/2023 | -21.31% | Raymond James | $260 → $250 | Maintains | Outperform | |||
07/28/2023 | -18.17% | Raymond James | $270 → $260 | Downgrade | Strong Buy → Outperform | |||
07/27/2023 | -18.17% | Raymond James | → $260 | Downgrade | Strong Buy → Outperform | |||
07/17/2023 | -23.52% | Wells Fargo | $249 → $243 | Maintains | Equal-Weight | |||
06/20/2023 | -21% | Morgan Stanley | → $251 | Initiates | → Equal-Weight | |||
05/23/2023 | -27.61% | BMO Capital | $260 → $230 | Maintains | Market Perform | |||
05/02/2023 | -21% | Citigroup | $256 → $251 | Maintains | Neutral | |||
05/01/2023 | -10.3% | Keefe, Bruyette & Woods | $289 → $285 | Maintains | Outperform | |||
05/01/2023 | -19.11% | Baird | $259 → $257 | Maintains | Outperform | |||
04/28/2023 | -15.02% | Raymond James | $275 → $270 | Maintains | Strong Buy | |||
04/28/2023 | -21.63% | Wells Fargo | $255 → $249 | Maintains | Equal-Weight | |||
04/18/2023 | -9.04% | Keefe, Bruyette & Woods | $303 → $289 | Maintains | Outperform | |||
04/18/2023 | -19.42% | Citigroup | $255 → $256 | Maintains | Neutral | |||
04/10/2023 | -27.61% | Jefferies | $235 → $230 | Maintains | Hold | |||
02/27/2023 | -8.72% | Goldman Sachs | → $290 | Upgrade | Neutral → Buy | |||
02/16/2023 | -18.48% | Baird | $246 → $259 | Maintains | Outperform | |||
02/14/2023 | -19.74% | Stifel | $228 → $255 | Maintains | Hold | |||
01/20/2023 | -18.17% | BMO Capital | → $260 | Initiates | → Market Perform | |||
01/18/2023 | -19.74% | Wells Fargo | $218 → $255 | Maintains | Equal-Weight | |||
01/18/2023 | -4.63% | Keefe, Bruyette & Woods | → $303 | Upgrade | Market Perform → Outperform | |||
01/17/2023 | -11.87% | Piper Sandler | $250 → $280 | Maintains | Overweight | |||
01/09/2023 | -14.7% | Goldman Sachs | $229 → $271 | Maintains | Neutral | |||
12/29/2022 | -11.87% | Raymond James | $250 → $280 | Maintains | Strong Buy | |||
12/15/2022 | -4.95% | Credit Suisse | $288 → $302 | Maintains | Outperform | |||
12/15/2022 | -22.26% | Citigroup | → $247 | Initiates | → Neutral | |||
12/05/2022 | -10.3% | MKM Partners | $250 → $285 | Maintains | Buy | |||
11/22/2022 | -24.46% | Morgan Stanley | $242 → $240 | Maintains | Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Willis Towers Watson (WTW) ?
Le dernier objectif de prix pour Willis Towers Watson (NASDAQ:WTW) a été rapporté par UBS le octobre 8, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $398.00 s'attendant à ce que WTW se rise dans les 12 prochains mois (un possible changement de 25.27% upside). 25 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Willis Towers Watson (WTW) ?
La dernière note d'analyste pour Willis Towers Watson (NASDAQ:WTW) a été fournie par UBS, et Willis Towers Watson maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Willis Towers Watson (WTW) ?
La dernière amélioration pour Willis Towers Watson PLC a eu lieu le mars 18, 2025 lorsque UBS a augmenté leur objectif de prix à $395. UBS avait précédemment a neutral pour Willis Towers Watson PLC.
Quand a eu lieu la dernière dégradation pour Willis Towers Watson (WTW) ?
La dernière réduction pour Willis Towers Watson PLC a eu lieu le août 8, 2023 lorsque BMO Capital a changé leur objectif de prix de $230 à $205 pour Willis Towers Watson PLC.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Willis Towers Watson (WTW) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Willis Towers Watson, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Willis Towers Watson a été déposée le octobre 8, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 8, 2026.
La note d'analyste pour Willis Towers Watson (WTW) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Willis Towers Watson (WTW) était un maintenu avec un objectif de prix de $395.00 à $398.00. Le prix actuel de Willis Towers Watson (WTW) est de $317.71, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.